The country will buy another 1.1 million jabs from China, while Covax has promised 17 million doses of the Oxford-AstraZeneca vaccine in the first half of the year Representational image. …
Sinopharm
-
- News
Hungary becomes first country in EU to approve Chinese vaccine Sinopharm as Europe grapples with virus
As Europe grapples with vaccine distribution, Hungary has become the first European Union(EU) country to approve the Chinese coronavirus vaccine Sinopharm. Hungary is expected to order 500,000 doses of the …
-
A model of a coronavirus is displayed next to boxes for Covid-19 vaccines at an exhibit by Chinese pharmaceutical firm Sinopharm at the China International Fair for Trade in Services …
-
The vaccine is the first one approved for general use in China. China has given conditional approval to a coronavirus vaccine developed by state-owned Sinopharm. The vaccine is the first …
-
Interim analysis of Phase 3 clinical trials show the vaccine is safe and people who received two doses produced high-level antibodies, according to a statement published Wednesday by Beijing Biological …
-
Beijing: Phase 3 trials of a Sinopharm coronavirus vaccine found it was 79 percent effective, the Chinese pharma giant said Wednesday, lower than rival jabs developed by Pfizer-BioNTech and Moderna …
-
LIMA: Peru suspended trials for China’s Sinopharm COVID-19 vaccine due to a “serious adverse event” that occurred with one of the volunteers for the study, the Peruvian government said in …
-
An exhibitor shows inactivated COVID-19 vaccine candidate from China National Biotec Group of Sinopharm Group during the 2020 China International Fair for Trade in Services at the Beijing Olympic Park …
-
Sinopharm claims its vaccine, which is being tested, has ‘no severe adverse reaction’. Nearly a million people have taken an experimental coronavirus vaccine developed by Chinese company Sinopharm, the firm …